Sergio
Vaño Galván
Profesor/a Asociado/a en CC. de la Salud
University of Bologna
Bolonia, Italia
2025
-
COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
JEADV Clinical Practice, Vol. 4, Núm. 4, pp. 811-820
-
Epistasis of ERAP1 with 4 Major Histocompatibility Complex Class i Alleles in Frontal Fibrosing Alopecia: A Genome-Wide Association Study Meta-Analysis
JAMA Dermatology, Vol. 161, Núm. 3, pp. 310-314
-
Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement
JAMA dermatology, Vol. 161, Núm. 1, pp. 87-95
-
Pediatric Pityriasis Amiantacea: A Multicenter Retrospective Study of 76 Patients
Skin Appendage Disorders
-
Quality of life, psychosocial difficulties and bullying in paediatric patients with alopecia areata: A European cross-sectional study
British Journal of Dermatology, Vol. 193, Núm. 6, pp. 1165-1173
-
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
Journal of the European Academy of Dermatology and Venereology
-
Trichoteiromania: A multicentre retrospective descriptive and analytical study of 129 cases
Journal of the European Academy of Dermatology and Venereology
2024
-
A comprehensive literature review and an international expert consensus on the management of scalp seborrheic dermatitis in adults
European journal of dermatology : EJD
-
Acne keloidalis nuchae: An international multicentric review of 79 patients
Journal of the European Academy of Dermatology and Venereology
-
Baricitinib Withdrawal and Retreatment in Patients with Severe Alopecia Areata: The BRAVE-AA1 Randomized Clinical Trial
JAMA Dermatology, Vol. 160, Núm. 10, pp. 1075-1081
-
Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
Dermatology and Therapy, Vol. 14, Núm. 4, pp. 1027-1037
-
Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
JEADV Clinical Practice, Vol. 3, Núm. 5, pp. 1564-1569
-
European expert consensus statement on the systemic treatment of alopecia areata
Journal of the European Academy of Dermatology and Venereology, Vol. 38, Núm. 4, pp. 687-694
-
Folliculitis decalvans in women: A retrospective multicentre study of 150 patients
Journal of the European Academy of Dermatology and Venereology
-
The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results from a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity
JAMA Dermatology, Vol. 160, Núm. 3, pp. 341-350
2023
-
Clinical benefit and tolerance profile of a keratolytic and hydrating shampoo in subjects with mild to moderate psoriasis. Results from a double-blind, randomized, vehicle-controlled study
Journal of Cosmetic Dermatology, Vol. 22, Núm. 7, pp. 2050-2053
-
Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries
Dermatology and Therapy, Vol. 13, Núm. 12, pp. 3121-3135
-
Shared Genetic Risk Variants in Both Male and Female Frontal Fibrosing Alopecia
Journal of Investigative Dermatology, Vol. 143, Núm. 11, pp. 2311-2314.e5
2022
-
Refractory folliculitis decalvans treated with adalimumab: A case series of 23 patients
Journal of the American Academy of Dermatology, Vol. 87, Núm. 3, pp. 666-669
2021
-
A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)
JAMA Dermatology, Vol. 157, Núm. 4, pp. 439-448